← Back to Clinical Trials
Recruiting NCT06079424
Risk Markers of Arterial Aging. The Paris Prospective Study III-2
Trial Parameters
Condition Arterial Stiffness
Sponsor Institut National de la Santé Et de la Recherche Médicale, France
Study Type OBSERVATIONAL
Phase N/A
Enrollment 7,500
Sex ALL
Min Age 60 Years
Max Age 95 Years
Start Date 2025-06-20
Completion 2031-05
Interventions
high-precision carotid echo-tracking
Brief Summary
The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.
Eligibility Criteria
Inclusion Criteria: * Being enrolled in PPS3 and having signed an informed consent for PPS3-2 Exclusion Criteria: * Institutionalized participants * Participants under guardianship * Participants under judicial safeguard measure
Related Trials
NCT06735599
Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure
View Trial →
NCT07324902
The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial Deformation
View Trial →
NCT04783597
Early Prediction of Preeclampsia Using arteriaL Stiffness in High-risk prEgnancies
View Trial →